Accumulating studies have demonstrated the pivotal immunomodulatory roles of CD100 in various pathological conditions, including anti-infection immunity, autoimmune disorders, and tumor immune microenvironment regulation [4,5,6]. This evidence concerns the gene SEMA4D and neoplasm.